Cellinobio
Cellino Bio develops AI-driven optical bioprocessing technology for personalized regenerative medicine. Its proprietary Nebula platform combines deep learning, laser-based cell management, and closed-loop optical bioprocesses to manufacture patient-specific, induced-pluripotent-stem-cell-derived cell and tissue replacements at scale. The company targets degenerative and chronic conditions including kidney disease, lung disease, spinal cord injury, Alzheimer's, and diabetes. Cellino is a life-sciences/biotech company with no public developer API surface; this profile is maintained in the API Evangelist network for company intelligence and is backed by Felicis and Khosla Ventures.
Cellinobio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Regenerative Medicine, Cell Therapy, and Artificial Intelligence.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API